Correlation Between OBI Pharma and Connection Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Connection Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Connection Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and Connection Technology Systems, you can compare the effects of market volatilities on OBI Pharma and Connection Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Connection Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Connection Technology.

Diversification Opportunities for OBI Pharma and Connection Technology

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between OBI and Connection is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Connection Technology Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connection Technology and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Connection Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connection Technology has no effect on the direction of OBI Pharma i.e., OBI Pharma and Connection Technology go up and down completely randomly.

Pair Corralation between OBI Pharma and Connection Technology

Assuming the 90 days trading horizon OBI Pharma is expected to under-perform the Connection Technology. But the stock apears to be less risky and, when comparing its historical volatility, OBI Pharma is 1.69 times less risky than Connection Technology. The stock trades about -0.05 of its potential returns per unit of risk. The Connection Technology Systems is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,540  in Connection Technology Systems on September 12, 2024 and sell it today you would lose (450.00) from holding Connection Technology Systems or give up 17.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OBI Pharma  vs.  Connection Technology Systems

 Performance 
       Timeline  
OBI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Connection Technology 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Connection Technology Systems are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Connection Technology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

OBI Pharma and Connection Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OBI Pharma and Connection Technology

The main advantage of trading using opposite OBI Pharma and Connection Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Connection Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connection Technology will offset losses from the drop in Connection Technology's long position.
The idea behind OBI Pharma and Connection Technology Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios